article thumbnail

April 16, 2025: In This Week’s PCT Grand Rounds, Colchicine and Spironolactone After Myocardial Infarction

Rethinking Clinical Trials

Jolly is an interventional cardiologist at Hamilton Health Sciences and the Stuart Connolly Chair in Cardiology and a professor of medicine at McMaster University. .” The Grand Rounds session will be held on Friday, April 18, 2025, at 1:00 pm eastern. Join the online meeting.

article thumbnail

Advancing cardiac care through health information technology

Bio Pharma Dive

A talk with the American College of Cardiology about how they are working with Health IT to deliver their guidance to the point-of-care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bayer and Evotec link to develop precision cardiology therapeutics

Pharmaceutical Technology

Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases (CVDs).

article thumbnail

New 2023 guidelines for the management of cardiomyopathies

Pharmaceutical Technology

A new set of European Society of Cardiology (ESC) guidelines was shared at the 2023 ESC conference in Amsterdam, Netherlands.

article thumbnail

Cardiology collaboration advances machine learning predictions for AFib after stroke

Medical Xpress

Researchers at Penn State are using machine learning and existing electrocardiogram (ECG) data to help doctors make more accurate predictions.

article thumbnail

Grand Rounds March 21, 2025: Generative Artificial Intelligence in Clinical Trials: A Driver of Efficiency and Democratization of Care (Alexander J. “AJ” Blood, MD, MSc)

Rethinking Clinical Trials

The ACT team has started to pilot this technology in other disease areas, including cardiology more broadly, endocrinology, oncology, and gastroenterology. While this tool can do a lot of analytical work, a human element will be essential to utilizing it effectively and to bringing human intelligence to participant enrollment.

article thumbnail

Pfizer buys immuno-inflammatory firm Arena Pharmaceuticals for $6.7b

Outsourcing Pharma

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.